SG11202003512YA - Stable liquid composition of ketoprofen, salts and enantiomers thereof - Google Patents
Stable liquid composition of ketoprofen, salts and enantiomers thereofInfo
- Publication number
- SG11202003512YA SG11202003512YA SG11202003512YA SG11202003512YA SG11202003512YA SG 11202003512Y A SG11202003512Y A SG 11202003512YA SG 11202003512Y A SG11202003512Y A SG 11202003512YA SG 11202003512Y A SG11202003512Y A SG 11202003512YA SG 11202003512Y A SG11202003512Y A SG 11202003512YA
- Authority
- SG
- Singapore
- Prior art keywords
- ketoprofen
- enantiomers
- salts
- liquid composition
- stable liquid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17204585 | 2017-11-30 | ||
| PCT/EP2018/082754 WO2019105957A1 (en) | 2017-11-30 | 2018-11-28 | Stable liquid composition of ketoprofen, salts and enantiomers thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202003512YA true SG11202003512YA (en) | 2020-05-28 |
Family
ID=60661746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202003512YA SG11202003512YA (en) | 2017-11-30 | 2018-11-28 | Stable liquid composition of ketoprofen, salts and enantiomers thereof |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20210260003A9 (en) |
| EP (1) | EP3716944A1 (en) |
| JP (1) | JP2021504306A (en) |
| KR (1) | KR20200094161A (en) |
| CN (1) | CN111526868A (en) |
| AU (1) | AU2018376176A1 (en) |
| BR (1) | BR112020009719A2 (en) |
| CA (1) | CA3079530A1 (en) |
| EA (1) | EA202091229A1 (en) |
| IL (1) | IL274672A (en) |
| MX (1) | MX2020005133A (en) |
| SG (1) | SG11202003512YA (en) |
| WO (1) | WO2019105957A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024071979A1 (en) * | 2022-09-29 | 2024-04-04 | 주식회사태준제약 | Ophthalmic composition comprising brimonidine |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1243342B (en) * | 1990-07-13 | 1994-06-10 | Farcon Ag | ORAL PHARMACEUTICAL COMPOSITIONS FOR LIQUID ANTI-INFLAMMATORY ACTIVITIES |
| US5183829A (en) | 1991-09-27 | 1993-02-02 | Applied Analytical Industries, Inc. | Oral liquid compositions of non-steroidal anti-inflammatory drugs |
| WO1997018245A1 (en) | 1995-11-14 | 1997-05-22 | Farmarc Nederland B.V. | Complex of naproxen and beta-cyclodextrin |
| IT1277741B1 (en) | 1995-12-28 | 1997-11-12 | Dompe Spa | PARENTERAL PHARMACEUTICAL COMPOSITIONS CONTAINING ALKYLAMMONIUM SALTS OF 2-ARYLPROPIONIC ACIDS |
| CN1263464A (en) | 1998-04-11 | 2000-08-16 | 伊利卡帕·尤罗特拉皮西有限公司 | Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application |
| AU2003246256A1 (en) | 2002-07-05 | 2004-01-23 | Able Corporation | Cell culture apparatus using hydroxyapatite and cell module |
| ITMI20032523A1 (en) | 2003-12-19 | 2005-06-20 | Acraf | DOSAGE FORM FOR ORAL USE INCLUDING A DRUG |
| KR20090010953A (en) | 2006-03-28 | 2009-01-30 | 자블린 파머슈티칼스 인코포레이티드 | Formulations of low dose non-steroidal anti-inflammatory drugs and beta-cyclodextrin |
| EP1974751A1 (en) * | 2007-03-26 | 2008-10-01 | The Jordanian Pharmaceutical Manufacturing Co. | Formulations for non-steroidal anti-inflammatory drugs |
| FR2950533B1 (en) | 2009-09-28 | 2012-01-13 | Maco Pharma Sa | LIQUID FORMULATION, STABLE, READY TO USE KETOPROFEN |
| TR201103183A1 (en) * | 2011-04-01 | 2012-10-22 | Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ | Topical pharmaceutical compositions of ketoprofen and methylsulfonylmethane. |
| JP2014513710A (en) * | 2011-05-20 | 2014-06-05 | アバンテイス・フアルマ・エス・アー | Pharmaceutical composition comprising ketoprofen |
| US8822537B2 (en) * | 2012-09-27 | 2014-09-02 | Achelios Therapeutics, Inc. | Topical ketoprofen composition |
-
2018
- 2018-11-28 SG SG11202003512YA patent/SG11202003512YA/en unknown
- 2018-11-28 US US16/764,624 patent/US20210260003A9/en not_active Abandoned
- 2018-11-28 WO PCT/EP2018/082754 patent/WO2019105957A1/en unknown
- 2018-11-28 EA EA202091229A patent/EA202091229A1/en unknown
- 2018-11-28 AU AU2018376176A patent/AU2018376176A1/en not_active Abandoned
- 2018-11-28 MX MX2020005133A patent/MX2020005133A/en unknown
- 2018-11-28 CN CN201880074027.1A patent/CN111526868A/en active Pending
- 2018-11-28 EP EP18811502.6A patent/EP3716944A1/en not_active Withdrawn
- 2018-11-28 JP JP2020526110A patent/JP2021504306A/en active Pending
- 2018-11-28 KR KR1020207017201A patent/KR20200094161A/en unknown
- 2018-11-28 BR BR112020009719-5A patent/BR112020009719A2/en not_active Application Discontinuation
- 2018-11-28 CA CA3079530A patent/CA3079530A1/en not_active Abandoned
-
2020
- 2020-05-14 IL IL274672A patent/IL274672A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2020005133A (en) | 2020-11-06 |
| JP2021504306A (en) | 2021-02-15 |
| WO2019105957A1 (en) | 2019-06-06 |
| EA202091229A1 (en) | 2020-08-19 |
| BR112020009719A2 (en) | 2020-10-27 |
| AU2018376176A1 (en) | 2020-07-02 |
| IL274672A (en) | 2020-06-30 |
| US20210260003A9 (en) | 2021-08-26 |
| EP3716944A1 (en) | 2020-10-07 |
| CN111526868A (en) | 2020-08-11 |
| KR20200094161A (en) | 2020-08-06 |
| CA3079530A1 (en) | 2019-06-06 |
| US20200281879A1 (en) | 2020-09-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3200586A4 (en) | Antimicrobial coating for long-term disinfection of surfaces | |
| ZA202003663B (en) | Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
| HK1258704A1 (en) | Drug composition and coating | |
| ZA201907313B (en) | Stable liquid pharmaceutical composition | |
| EP3294205A4 (en) | Dental solution dispenser and methods of use | |
| DK3241551T3 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CANCER CONTAINING LACTATE METAL SALT | |
| EP3395325A4 (en) | Liquid cosmetic composition | |
| GB201718468D0 (en) | Stable liquid pharmaceutical compositions of bortezomb | |
| IL274672A (en) | Stable liquid composition of ketoprofen, salts and enantiomers thereof | |
| PL3349594T3 (en) | Salt substitute composition and use thereof | |
| EP3344242A4 (en) | Stable multiparticuate pharamaceutical composition of rosuvastatin | |
| EP3156040A4 (en) | Cosmetic composition containing 3-o-alkyl-l-ascorbic acid or salt thereof | |
| ZA201907515B (en) | Process for the preparation of pirlindole enantiomers and its salts | |
| EP3231422A4 (en) | Application of atractylenolide compound or derivative thereof and anti-platelet aggregation drug | |
| HK1254738A1 (en) | Composition for minimum quantity lubrication, and use of same | |
| EP3294707A4 (en) | Manufacture of organopolysulfides and salts thereof | |
| ZA201908264B (en) | Formulations of homotaurines and salts thereof | |
| HK1257509A1 (en) | Pulsatile release pharmaceutical composition comprising naftazone or one of its salts | |
| SI3612535T1 (en) | Process for the preparation of pirlindole enantiomers and its salts | |
| PL3612535T3 (en) | Process for the preparation of pirlindole enantiomers and its salts | |
| GB201621771D0 (en) | New salts of compounds and uses thereof | |
| PT3185855T (en) | Film coated tablet for the treatment of acute pain | |
| TH1501005877A (en) | Composition and methods for increasing the stability of microorganisms |